1. Home
  2. KOSS vs SCLX Comparison

KOSS vs SCLX Comparison

Compare KOSS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • SCLX
  • Stock Information
  • Founded
  • KOSS 1953
  • SCLX 2011
  • Country
  • KOSS United States
  • SCLX United States
  • Employees
  • KOSS N/A
  • SCLX N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOSS Consumer Staples
  • SCLX Health Care
  • Exchange
  • KOSS Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • KOSS 43.6M
  • SCLX 35.7M
  • IPO Year
  • KOSS N/A
  • SCLX N/A
  • Fundamental
  • Price
  • KOSS $4.50
  • SCLX $18.77
  • Analyst Decision
  • KOSS
  • SCLX Hold
  • Analyst Count
  • KOSS 0
  • SCLX 1
  • Target Price
  • KOSS N/A
  • SCLX N/A
  • AVG Volume (30 Days)
  • KOSS 55.8K
  • SCLX 164.6K
  • Earning Date
  • KOSS 10-30-2025
  • SCLX 08-13-2025
  • Dividend Yield
  • KOSS N/A
  • SCLX N/A
  • EPS Growth
  • KOSS N/A
  • SCLX N/A
  • EPS
  • KOSS N/A
  • SCLX N/A
  • Revenue
  • KOSS $13,493,080.00
  • SCLX $44,236,000.00
  • Revenue This Year
  • KOSS N/A
  • SCLX $89.26
  • Revenue Next Year
  • KOSS N/A
  • SCLX $203.95
  • P/E Ratio
  • KOSS N/A
  • SCLX N/A
  • Revenue Growth
  • KOSS 11.58
  • SCLX N/A
  • 52 Week Low
  • KOSS $4.00
  • SCLX $3.60
  • 52 Week High
  • KOSS $8.59
  • SCLX $39.20
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 36.43
  • SCLX 53.24
  • Support Level
  • KOSS $4.59
  • SCLX $16.05
  • Resistance Level
  • KOSS $4.78
  • SCLX $21.00
  • Average True Range (ATR)
  • KOSS 0.26
  • SCLX 1.90
  • MACD
  • KOSS -0.03
  • SCLX 0.43
  • Stochastic Oscillator
  • KOSS 14.75
  • SCLX 71.97

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: